Behavioral Targeting: RJ vs JP Posted: June 15, 2006 Just when you thought it was safe to go back in the water...bam! In this case, the water is tracking consumer website visits for targeted marketing. It's a tactic being advocated by my friend R.J. Lewis, President and CEO e-Healthcare Solutions, Inc., (aka RJ), in his "Eye on E-Marketing" column in the May, 2006 issue of Product Management Today. Unfortunately, the last time it was employed by pharmaceutical marketers, it blew up in their faces. Jean Paul Hepp, Pfizer's Chief Privacy Officer, (aka, JP), can tell you all about it. For more on this, see today's post to Pharma Marketing Blog. More posts about eMarketing Blog Topics. | Return to Pharma Marketing Blog Topics |

Special Supplement ePharma Marketing Many experts believe that pharma eMarketing is at a tipping point and that pharmaceutical companies are poised to shift substantial ad spending from TV and other media to the Internet. The selection of articles in this Special Supplement to Pharma Marketing News was chosen to give you a better perspective on pharma eMarketing. Included are real world case studies that illustrate the advantages of eMarketing such as depth of information, interaction, relationship building and superior customer engagement. TABLE OF CONTENTS Order and pay for this Special Supplement now using your credit card ONLY $29.95 PDF file delivered to you by email (usually within minutes of placing your order): If you wish to pay by check or credit card off-line, please use: Printable Order Form